The purpose of this study is to evaluate predictors of success of repeated injections of methotrexate in the single-dose regimen for the treatment of tubal ectopic pregnancy. All patients who had ectopic tubal pregnancy and were treated with a single dose regimen were retrospectively identified. 126 patients were treated with methotrexate. Among them, 39 patients were adequate for this study. 33 were treated with the 2nd dose and 27 were successfully cured. Additionally, 6 who were injected with the 3rd dose were all cured as well. Therefore, in our study, the success rate for the repeated injections of methotrexate was found to be 84.6% (33/39). The mean initial β-hCG level was significantly lower in patients who were successfully treated than in patients who failed (3915.3±3281.3 vs. 8379.7±2604.4 IU/mL, p
展开▼
机译：本研究的目的是评估在单剂量方案中重复注射甲氨蝶呤的成功的预测因素，用于治疗输卵管异位妊娠。回顾性鉴定了所有患有异位输卵管妊娠并用单剂量方案治疗的患者。用甲氨蝶呤治疗126名患者。其中，39例患者足以进行这项研究。 33用2ND剂量处理，27次成功固化。此外，6种被注射3次注射的6人也均固化。因此，在我们的研究中，发现重复注射甲氨蝶呤的成功率为84.6％（33/39）。成功处理的患者的平均初始β-HCG水平明显低于失败的患者（3915.3±3281.3与8379.7±2604.4 IU / ml，p
展开▼
